Reducing human suffering by detecting cancer earlier with patented technology
BioCurex's RECAF(tm) marker is found in all types of major cancers
  • Demo Video
  • Private Messages
  • Edit My Profile
  • View/Edit Portfolio

Email Updates

Search

AGORACOM News Flash


AGORACOM WIRE .... WEEKEND EDITION

TOP STORY .... AGORACOM Launches GraphiteStocksBlog.com

We're proud to announce the launch of GraphiteStocksBlog.com a website dedicated to the needs of investors and companies in the fast growing Graphite industry.

INAUGURAL GRAPHITE SPONSORS

 

AGORACOM INTERVIEWS ERIC SPROTT: Eric Discusses UC Resources $1.5M Investment INTO Sprott + Current And Future Silver Path

Message: Is selling the company an option?

Banned_profile
This user has been banned for violating Agoracom's Six Rules of Use

Is selling the company an option?

posted on Nov 25, 08 05:24AM

Dr. Moro. In the latest filing, the current cash position is $90,000 which is not enough to continue current operations. If you cannot obtain more funding to pay the loan, will the lack of money cause the company be sold? Does the hedge fund have any lien on the latest patents or any additional patent grants? Does the hedge fund have any lien on BioCurex China?

New Message

Please login to post a reply

AGORACOM Quick Tips

250,000 oz of Gold in Past Production ... Learn More!
Watch
Today's Show
in 00:00:000

President's D.D.

New feature: Hub Presidents can add important links here.

Stock Quote